ALX Oncology Inc.

NASDAQ: ALXO · Real-Time Price · USD
0.64
-0.02 (-2.29%)
At close: Aug 15, 2025, 3:59 PM
0.64
0.59%
After-hours: Aug 15, 2025, 05:02 PM EDT

ALX Oncology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-116.57M -130.02M -134.85M -151.16M -171.44M -166.2M -160.81M -146.04M -130.37M -129.13M -123.48M -121.21M -110.46M -93.81M -83.46M -73.8M -59.41M -54.47M
Depreciation & Amortization
840K 869K 872K 865K 850K 837K 836K 734K 620K 497K 342K 271K 182K 104K 51K 22K 21K 94K
Stock-Based Compensation
20.16M 25.28M 27.09M 27.96M 27.97M 26.95M 26.27M 25.85M 25.09M 24.69M 23.84M 23.23M 21.21M 17.61M 13.91M 9.97M 6.47M 7.08M
Other Working Capital
-9.04M -579K -8.01M 1.78M 8.15M 6.82M 11.29M 7.99M 2.75M 6M 4.09M 3.17M 604K -10.84M -7.32M -7.92M -5.34M 1.91M
Other Non-Cash Items
2.69M -1.55M -2.6M 7.75M 8.65M 9.86M 10.15M -340K -410K -586K 587K 5.88M 5.84M 5.79M 5.42M 542K 278K 245K
Deferred Income Tax
n/a n/a n/a -11.62M -13.46M -15.11M -15.11M -3.49M -1.65M n/a n/a n/a n/a n/a n/a 621K 863K 1.17M
Change in Working Capital
-12.61M -3.23M -12.43M -3.34M 12.11M 3.19M 8.3M 11.94M -4M 8.53M 9.85M 6.14M 3.21M -13.34M -4.03M -1.58M 2.86M 11.41M
Operating Cash Flow
-105.49M -108.65M -121.91M -129.54M -135.33M -140.47M -130.36M -111.35M -111.08M -96.36M -89.22M -86.04M -80.02M -83.64M -68.1M -64.23M -48.92M -34.46M
Capital Expenditures
-316K -359K -447K -535K 917K -732K -1.27M -1.51M -3.01M -1.53M -1.43M -5.56M -5.76M -5.5M -4.92M -416K -28K -28K
Cash Acquisitions
n/a n/a n/a 50.94K 50.94K 42.98K n/a -62.27K -62.27K 21.56K 64.54K 75.88K 75.88K n/a n/a n/a n/a n/a
Purchase of Investments
-54.33M -91.9M -107.41M -177.97M -222.15M -205.71M -246.63M -232.59M -216.31M -265.66M -376.79M -315.82M -279.21M -183.33M n/a n/a n/a n/a
Sales Maturities Of Investments
163.49M 179.68M 194.11M 214.91M 244.76M 235.28M 292.56M 306.37M 292.47M 257.99M 142.8M 70.5M 20M n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a -50.94K -50.94K -42.98K n/a 62.27K 76.16K -7.67K -233.99K -4.5M -4.52M -4.44M -4.26M n/a 641K 641K
Investing Cash Flow
108.84M 87.43M 86.26M 36.41M 23.53M 28.84M 44.66M 72.27M 73.14M -9.2M -235.42M -250.88M -264.97M -188.84M -4.92M -416K 613K 613K
Debt Repayment
-978K -959K -827K -814K -567K -456K -388K 8.91M 8.88M 8.96M 8.96M -385K -348K -313K -208K -104K n/a n/a
Common Stock Repurchased
15K n/a n/a n/a n/a n/a n/a 336K 336K 336K 336K n/a n/a n/a n/a -179.28M -179.28M -179.28M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -3K -3K -3K
Other Financial Acitivies
30.24M 31.41M 31.64M 1.94M 1.4M 687K 450K 450K 455K 462K 647K 1.27M 1.81M 2.09M 2.68M 190.42M 187.45M 186.26M
Financial Cash Flow
422K 27.8M 30.82M 89.66M 89.29M 62.48M 59.29M 9.62M 9.59M 9.67M 9.86M 890K 1.47M 1.77M 2.47M 190.31M 360.17M 358.67M
Net Cash Flow
3.77M 6.57M -4.84M -3.48M -22.5M -49.15M -26.42M -29.47M -28.34M -95.89M -314.78M -336.03M -343.52M -270.7M -70.55M 125.67M 311.86M 324.82M
Free Cash Flow
-105.81M -109.01M -122.36M -130.08M -134.41M -141.2M -131.64M -112.87M -114.09M -97.89M -90.65M -91.6M -85.78M -89.14M -73.02M -64.64M -48.95M -34.49M